トップページ > 業績

2020年論文

英文論文

  • Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients
    Inubushi S, Kawaguchi H, Mizumoto S, Kunihisa T, Baba M, Kitayama Y, Takeuchi T, Hoffman RM, Sasaki R.
    Anticancer Res. 2020 Jun;40(6):3091-3096.
  • Chyle Leakage After Axillary Node Sampling in a Patient With Breast Cancer: A Case Report
    Kohno N, Kimoto T, Okamoto A, Tanino H.
    Surg Case Rep. 2020 Jun 1;6(1):119.
  • Antibody-Conjugated Signaling Nanocavities Fabricated by Dynamic Molding for Detecting Cancers Using Small Extracellular Vesicle Markers From Tears
    Takeuchi T, Mori K, Sunayama H, Takano E, Kitayama Y, Shimizu T, Hirose Y, Inubushi S, Sasaki R, Tanino H.
    J Am Chem Soc. 2020 Apr 8;142(14):6617-6624.
  • Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
    Yamamoto J, Murata T, Sugisawa N, Higuchi T, Tashiro Y, Nishino H, Inubushi S, Sun YU, Lim H, Miyake K, Shimoya K, Nomura T, Kurebayashi J, Tanino H, Hozumi C, Bouvet M, Singh SR, Endo I, Hoffman RM.
    Anticancer Res. 2020 May;40(5):2475-2479.
  • A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
    Yamamoto J, Murata T, Tashiro Y, Higuchi T, Sugisawa N, Nishino H,Inubushi S, Sun YU, Lim H, Miyake K, Hongo A, Nomura T, Saitoh W, Moriya T, Tanino H, Hozumi C, Bouvet M, Singh SR, Endo I, Hoffman RM.
    Anticancer Res. 2020 May;40(5):2509-2514.
  • BRCAness as an Important Prognostic Marker in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
    Kosaka Y, Yamamoto Y, Tanino H, Nishimiya H, Yamamoto-Ibusuki M, Hirota Y, Iwase H, Nakamura S, Akashi-Tanaka S.
    Diagnostics (Basel). 2020 Feb 21;10(2):119.
  • A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts
    Yamamoto J, Sugisawa N, Hamada K, Nishino H, Miyake K, Matsuyama R, Inubushi S, Tanino H, Bouvet M, Endo I, Hoffman RM.
    Anticancer Res. 2020 Dec;40(12):6765-6768.
  • Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice: Toward the Goal of Universal Individualized Cancer Therapy
    Murata T, Hozumi C,Hiroshima Y, Shimoya K, Hongo A, Inubushi S, Tanino H, Hoffman RM.
    In Vivo. 2020 Nov-Dec;34(6):3241-3245.
  • Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsy
    Narui K, Ishikawa T, Oba MS, Hasegawa Y, Kaise H, Kawate T, Yamada A, Yamada K, Suzuki Y, Niikura N, Kohno N, Kimoto T, Sugae S, Kosaka Y, Miyashita M, Okamura T, Shimizu D, Tanino H, Tanabe M, Morita S, Endo I, Tokuda Y.
    Surg Oncol. 2020 Dec;35:447-452.

邦文論文

  • 【ゲノム医療とがん看護~私たちはなにを知って,なにをする?~】がんゲノム医療の「いま」を知る! 乳がん患者へのがんゲノム医療 医師の立場から
    國久 智成、豊田 昌徳
    がん看護 (1342-0569)25巻8号 Page739-741
  • 頭蓋底骨転移により多発脳神経障害を認めた乳癌の2例
    曽山 みさを、國久 智成、岡本 葵、三木 万由子、水本 紗千子、谷野 裕一、西岡 瑛子
    日本臨床外科学会雑誌 (1345-2843)81巻9号 Page1742-1747
  • 【Women's Imaging 2020 Breast Imaging Vol.15 乳がんの個別化医療、ゲノム医療の幕開けと画像診断の展望】乳がん画像診断の最新技術動向 マイクロ波マンモグラフィの技術と研究・開発の動向
    木村 健次郎、稲垣 明里、前澤 眞之、中島 義晴、木村 憲明、河野 誠之、八木 潤子、岡本 交二、國久 智成、谷野 裕一、高尾 信太郎、山神 和彦
    INNERVISION (0913-8919)35巻8号 Page52-57
  • 在宅とつくるこれからのAdvance Care Planning スタッフのためのAdvance Care Planning(Advance Care Planning for Staff)
    谷野 裕一、川床 優子、鈴木 美智子
    Palliative Care Research (1880-5302)15巻Suppl. Page S180
  • 二期的に乳房再建を行った乳房原発隆起性線維肉腫の1例
    渡辺 理恵、水本 紗千子、國久 智成、箕畑 順也、大守 誠、寺村 一裕、脇田 和幸
    Oncoplastic Breast Surgery (2432-4647)5巻1号 Page24-29

PAGE TOP